Cargando…

Combined serum free light chain predicts prognosis in acute kidney injury following cardiovascular surgery

OBJECTIVES: Increased polyclonal free light chains (FLCs) are found in inflammatory conditions. Inflammation is recognized in the progression of acute kidney injury (AKI). This study was aimed to determine whether polyclonal combined FLC (cFLC) was associated with prognosis of AKI patients. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Wenji, Zhang, Lulu, Yang, Tianye, Ma, Shaojun, Zhang, Qi, Shi, Peng, Ding, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797736/ https://www.ncbi.nlm.nih.gov/pubmed/35086423 http://dx.doi.org/10.1080/0886022X.2021.2013886

Ejemplares similares

Serum indoxyl sulfate is associated with mortality in hospital-acquired acute kidney injury: a prospective cohort study
por: Wang, Wenji, et al.
Publicado: (2019)

Serum Immunoglobulin Free Light Chain Assessment in IgG4-Related Disease
por: Grados, Aurélie, et al.
Publicado: (2013)

Association between mineral and bone disorder in patients with acute kidney injury following cardiac surgery and adverse outcomes
por: Yang, Tianye, et al.
Publicado: (2019)

A case of light chain deposition disease involving the kidney with a normal serum free kappa/lambda light chain ratio
por: Zhang, Suojian, et al.
Publicado: (2022)

The Association between Polyclonal Combined Serum Free Light Chain Concentration and Mortality in Individuals with Early Chronic Kidney Disease
por: Assi, Lakhvir K., et al.
Publicado: (2015)

Light chain myeloma and detection of free light chains in serum and urine of dogs and cats
por: Harris, Robert Adam, et al.
Publicado: (2021)

Correction: The Association between Polyclonal Combined Serum Free Light Chain Concentration and Mortality in Individuals with Early Chronic Kidney Disease
por: Assi, Lakhvir K., et al.
Publicado: (2015)

Alteration of the Gut Microbiome in Chronic Kidney Disease Patients and Its Association With Serum Free Immunoglobulin Light Chains
por: Liu, Fengping, et al.
Publicado: (2021)

The Clinical Significance of Serum Free Light Chains in Bladder Cancer
por: Gudowska-Sawczuk, Monika, et al.
Publicado: (2023)

Novel renal replacement strategies for the elimination of serum free light chains in patients with kappa light chain nephropathy
por: Kleeberg, L, et al.
Publicado: (2009)

Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies
por: Tietsche de Moraes Hungria, Vania, et al.
Publicado: (2016)

Prognostic Significance of Serum Free Light Chains in Chronic Lymphocytic Leukemia
por: Sarris, Katerina, et al.
Publicado: (2013)

Serum Free Light Chain Only Myeloma with Cytoplasmic IgM
por: Ebana, Hideaki, et al.
Publicado: (2014)

Low serum free light chain is associated with risk of COPD exacerbation
por: Tanimura, Kazuya, et al.
Publicado: (2020)

Comparison of 2 Serum-Free Light-Chain Assays in CKD Patients
por: Sprangers, Ben, et al.
Publicado: (2020)

Serum free light chains and multiple myeloma: Is it time to extend their application?
por: Markovic, Uros, et al.
Publicado: (2020)

Comparison of serum and urine free light chain analysis in clinical diagnosis
por: Cho, Jooyoung, et al.
Publicado: (2022)

Detection of oligoclonal IgG kappa and IgG lambda bands in cerebrospinal fluid and serum with Hevylite™ antibodies. comparison with the free light chain oligoclonal pattern
por: Zeman, David, et al.
Publicado: (2012)

Disease spectrum of abnormal serum free light chain ratio and its diagnostic significance
por: Xu, Bin, et al.
Publicado: (2017)

Combined crystal-storing histiocytosis, light chain proximal tubulopathy, and light chain crystalline podocytopathy in a patient with multiple myeloma: a case report and literature review
por: Zhu, Li, et al.
Publicado: (2023)

Prognostic Value of Serum Free Light Chains Measurements in Multiple Myeloma Patients
por: García de Veas Silva, José Luis, et al.
Publicado: (2016)

Elevated serum polyclonal immunoglobulin free light chains in patients with severe asthma
por: Basile, Umberto, et al.
Publicado: (2023)

Kappa free light chains index in multiple sclerosis very long-term prognosis
por: Arroyo-Pereiro, Pablo, et al.
Publicado: (2023)

Serum Free Light Chains in Neoplastic Monoclonal Gammopathies: Relative Under-Detection of Lambda Dominant Kappa/Lambda Ratio, and Underproduction of Free Lambda Light Chains, as Compared to Kappa Light Chains, in Patients With Neoplastic Monoclonal Gammopathies
por: Lee, Won Sok, et al.
Publicado: (2018)

Serum free light chain levels and renal function at diagnosis in patients with multiple myeloma
por: Yadav, Punit, et al.
Publicado: (2018)

Polyclonal serum free light chain elevation is associated with increased risk of monoclonal gammopathies
por: Kumar, Shaji, et al.
Publicado: (2019)

Serum Free Immunoglobulins Light Chains: A Common Feature of Common Variable Immunodeficiency?
por: Guevara-Hoyer, Kissy, et al.
Publicado: (2020)

Inter-Laboratory Concordance of Cerebrospinal Fluid and Serum Kappa Free Light Chain Measurements
por: Natali, Patrizia, et al.
Publicado: (2022)

Multiple myeloma can be accurately diagnosed in acute kidney injury patients using a rapid serum free light chain test
por: Heaney, Jennifer L. J., et al.
Publicado: (2017)

Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study
por: Long, Thorir Einarsson, et al.
Publicado: (2022)

Helicobacter pylori Infection and Light Chain Gammopathy
por: Girón, José A., et al.
Publicado: (2013)

European trial of free light chain removal by extended haemodialysis in cast nephropathy (EuLITE): A randomised control trial
por: Hutchison, Colin A, et al.
Publicado: (2008)

P900: INVOLVED/UNINVOLVED SERUM FREE LIGHT CHAIN RATIO IS A STRONGER PREDICTOR OF DIAGNOSTIC/RISK FACTORS IN LIGHT CHAIN COMPARED TO HEAVY CHAIN MONOCLONAL GAMMOPATHIES
por: Thorir Oskarsson, Jon, et al.
Publicado: (2023)

In response to: Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: results of the iStopMM study
por: Minnema, Monique C., et al.
Publicado: (2022)

A Cohort Study of Free Light Chain Ratio in Combination with Serum Protein Electrophoresis as a First-Line Test in General Practice
por: Sandfeld-Paulsen, Birgitte, et al.
Publicado: (2022)

Multiple myeloma: Detection of free monoclonal light chains by modified immunofixation electrophoresis with antisera against free light chains
por: Wilhite, Dorian, et al.
Publicado: (2021)

Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure
por: Hutchison, Colin A, et al.
Publicado: (2008)

Diagnostic and mechanistic implications of serum free light chains, albumin and alpha-fetoprotein in hepatocellular carcinoma
por: Teng, M, et al.
Publicado: (2014)

Responses in multiple myeloma should be assigned according to serum, not urine, free light chain measurements
por: Dejoie, Thomas, et al.
Publicado: (2018)

Serum free light chain level at diagnosis in myeloma cast nephropathy—a multicentre study
por: Yadav, Punit, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dsr3q4t5nkueimrp2dg06t3rlo